Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 93
Filtrar
1.
Clin Lab ; 63(10): 1717-1722, 2017 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-29035461

RESUMO

BACKGROUND: The aim of this study was to determine the cerebrospinal fluid (CSF) and serum levels of EGF containing fibulin-like extracellular matrix protein 1 (EFEMP1) in the patients with meningiomas and explore its potential as a biomarker. METHODS: Forty-five patients with meningioma, 11 of whom underwent meningioma resection, as well as 30 healthy controls were enrolled in this study. CSF and blood samples were collected preoperatively and postoperatively. Expression levels of EFEMP1 were measured by enzyme-linked immunosorbent assay (ELISA). Receiver operating characteristic (ROC) curves were used to evaluate its discriminant ability. RESULTS: CSF EFEMP1 levels were significantly higher in the CSF samples (p < 0.0001) and serum samples (p = 0.0056) of meningioma patients compared to controls. To distinguish meningioma patients from controls by CSF and serum EFEMP1 levels, ROC/AUC analysis indicated an AUC of 0.945 (sensitivity 0.933; specificity 0.833) and an AUC of 0.674 (sensitivity 0.867; specificity 0.400), respectively. Moreover, the postoperative CSF levels of EFEMP1 were significantly decreased compared to the preoperative levels (p < 0.0001). CONCLUSIONS: The present study suggested that elevated EFEMP1 levels might be a novel diagnostic biomarker for meningioma patients.


Assuntos
Proteínas da Matriz Extracelular/líquido cefalorraquidiano , Neoplasias Meníngeas/líquido cefalorraquidiano , Meningioma/líquido cefalorraquidiano , Biomarcadores/sangue , Biomarcadores/líquido cefalorraquidiano , Estudos de Casos e Controles , Proteínas da Matriz Extracelular/sangue , Humanos , Neoplasias Meníngeas/sangue , Neoplasias Meníngeas/cirurgia , Meningioma/sangue , Meningioma/cirurgia , Regulação para Cima
2.
World Neurosurg ; 97: 178-188, 2017 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-27686504

RESUMO

BACKGROUND: Primary intraventricular meningiomas (IVMs) make up 0.5%-5% of all intracranial meningiomas and represent one of the most challenging lesions in neurosurgery. METHODS: Between 1990 and 2013, 42 patients (30 female, 12 male; mean age, 43.6 years) underwent resection of their IVM. The removal was performed by a posterior parietal approach in 19 of the 40 lateral ventricle tumors, and 1 third ventricle meningioma. The transcallosal approach was used for 3 meningiomas, and patients with other lesions underwent temporal (7 cases) and temporoparietal approaches (12 patients), respectively. RESULTS: The most common presenting signs were increased intracranial pressure (83.3%), visual impairment (78.6%) and cognitive changes (50%). Forty lesions (95.2%) arose in the lateral ventricles, and 2 (4.8%) in the third ventricle, ranging in size from 3 to 10 cm. Total removal was achieved in 39 cases and the pathology report disclosed World Health Organization grade I lesions in 41 cases. Hydrocephalus, cerebrospinal fluid leakage, and cerebral edema were the postoperative complications (7.15%); 1 patient died of respiratory problems not directly related to surgery. Thirty-five patients (83.3%) showed a 6-month Glasgow Outcome Scale of 5. One patient, who underwent partial resection, presented a recurrence after 1 year that remained stable until last follow-up. CONCLUSIONS: IVMs usually reach a large size before being diagnosed. Surgical treatment is the most suitable option and total removal should represent the main goal of the procedure. The posterior parietal transulcal approach and the temporoparietal approach are the most common surgical routes used in our series.


Assuntos
Neoplasias Meníngeas/diagnóstico por imagem , Neoplasias Meníngeas/cirurgia , Meningioma/líquido cefalorraquidiano , Meningioma/cirurgia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Feminino , Seguimentos , Humanos , Lactente , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto Jovem
3.
BMC Complement Altern Med ; 13: 303, 2013 Nov 04.
Artigo em Inglês | MEDLINE | ID: mdl-24188277

RESUMO

BACKGROUND: Currently, there are no consistently effective chemotherapies for recurrent and inoperable meningiomas. Recently, cucurbitacin I (JSI-124), a naturally occurring tetracyclic triterpenoid compound used as folk medicines has been found to have cytoxic and anti-proliferative properties in several malignancies thru inhibition of activator of transcription (STAT3) activation. Previously, we have found STAT3 to be activated in meningiomas, particularly higher grade tumors. METHODS: Primary leptomeningeal cultures were established from 17, 20 and 22 week human fetuses and meningioma cell cultures were established from 6 World Health Organization (WHO) grade I or II meningiomas. Cells were treated with cerebrospinal fluid from patients without neurologic disease. The effects of cucurbitacin I on cerebrospinal fluid stimulation of meningioma cell DNA synthesis phosphorylation/activation of JAK1, STAT3, pMEK1/2, p44/42MAPK, Akt, mTOR, Rb and caspase 3 activation were analyzed in human leptomeningeal and meningioma cells. RESULTS: Cerebrospinal fluid significantly stimulated DNA synthesis in leptomeningeal cells. Co-administration of cucurbitacin I (250 nM) produces a significant blockade of this effect. Cucurbitacin I alone also produced a significant reduction in basal DNA synthesis. In grade I and II meningiomas, cerebrospinal fluid also significantly stimulated DNA synthesis. Co-administration of cucurbitacin I (250 nM) blocked this effect.In the leptomeningeal cultures, cerebrospinal fluid stimulated STAT3 phosphorylation but not p44/42MAPK, Akt or mTOR. Cucurbitacin I had no effect on basal STAT3 phosphorylation but co-administration with cerebrospinal fluid blocked cerebrospinal fluid stimulation of STAT3 phosphorylation in each. In the grade I meningiomas, cerebrospinal fluid stimulated phosphorylation of STAT3 and decreased MEK1/2 and cucurbitacin I had no effect on basal STAT3, p44/42MAPK, Akt, JAK1, mTOR, or Rb phosphorylation. In the grade II meningiomas, cerebrospinal fluid stimulated STAT3 phosphorylation in all and reduced phosphorylation of MEK1/2 in all and p44/42MAPK in one. Cucurbitacin I had no effect on basal phosphorylation of STAT3 but reduced phorphorylated p44/42 MAPK in 2 grade II meningioma cells lines. CONCLUSIONS: These studies raise the possibility that cucurbitacin I might have value as an adjunct chemotherapy. Additional studies are warranted to evaluate the effects of cucurbitacin I on meningiomas in vivo.


Assuntos
Líquido Cefalorraquidiano/metabolismo , Neoplasias Meníngeas/genética , Meningioma/genética , Proteínas Proto-Oncogênicas c-sis/metabolismo , Triterpenos/farmacologia , Adulto , Idoso , Becaplermina , DNA/genética , DNA/metabolismo , Feminino , Humanos , Masculino , Neoplasias Meníngeas/líquido cefalorraquidiano , Neoplasias Meníngeas/tratamento farmacológico , Neoplasias Meníngeas/metabolismo , Meningioma/líquido cefalorraquidiano , Meningioma/tratamento farmacológico , Meningioma/metabolismo , Pessoa de Meia-Idade , Fosforilação/efeitos dos fármacos , Proteínas Proto-Oncogênicas c-akt/genética , Proteínas Proto-Oncogênicas c-akt/metabolismo , Fator de Transcrição STAT3/genética , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais/efeitos dos fármacos , Serina-Treonina Quinases TOR/genética , Serina-Treonina Quinases TOR/metabolismo , Células Tumorais Cultivadas
4.
BMJ Case Rep ; 20132013 Jun 21.
Artigo em Inglês | MEDLINE | ID: mdl-23813510

RESUMO

A 61-year-old woman had an intracranial tumour that was located on the falx. Meningioma was suspected and the tumour rapidly grew over 1 year. It showed nearly equal density with spinal fluid showing almost no enhancement on radiographic images, like microcystic meningioma. Successful removal of the tumour was achieved. Histopathologically, the tumour was diagnosed as low-grade meningioma. The meningioma had variable sized microcysts and the appearance of solid area was meningothelial meningioma. This is a rare radiographic image for meningothelial meningioma.


Assuntos
Neoplasias Encefálicas/diagnóstico por imagem , Meningioma/diagnóstico por imagem , Neoplasias Encefálicas/líquido cefalorraquidiano , Diagnóstico Diferencial , Feminino , Humanos , Meningioma/líquido cefalorraquidiano , Pessoa de Meia-Idade , Radiografia , Resultado do Tratamento
5.
Brain Tumor Pathol ; 30(3): 185-91, 2013 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-22915133

RESUMO

Benign spinal meningiomas have good prognoses, with low rates of recurrence and no cerebrospinal fluid (CSF) dissemination. However, we experienced an extremely rare case of initially benign non-dura-based spinal meningioma that showed multiple CSF disseminated lesions, which progressed for 14 years. A 29-year-old woman without neurofibromatosis presented with progressing dysesthesia in her lower limbs, low back pain, and intermittent claudication. Magnetic resonance imaging (MRI) showed an intradural extramedullary mass lesion at the Th10/11 level. The patient underwent a tumor resection. Intraoperative findings indicated that the tumor had no dural attachment. Histopathological diagnosis after gross total removal was microcystic meningioma (grade I, WHO 2007). Seven years after the first operation, other lesions appeared at the levels of Th11/12, L1, and L2/3 in MRI. These tumors were slow growing and became symptomatic; thus, a second surgery was performed 14 years after the first operation. The histopathological diagnosis was atypical meningioma (grade II, WHO 2007). Benign spinal meningiomas show CSF dissemination extremely rarely, although some authors have reported non-dura-based intraspinal clear-cell meningiomas showing CSF dissemination. However, even in cases of WHO grade I, neurosurgeons should pay attention to late CSF dissemination and malignant transformation after surgical removal of non-dura-based intraspinal meningiomas.


Assuntos
Transformação Celular Neoplásica/patologia , Neoplasias Meníngeas/líquido cefalorraquidiano , Neoplasias Meníngeas/patologia , Meningioma/líquido cefalorraquidiano , Meningioma/patologia , Adulto , Feminino , Humanos , Laminectomia/métodos , Imageamento por Ressonância Magnética , Neoplasias Meníngeas/cirurgia , Meningioma/cirurgia , Estadiamento de Neoplasias , Reoperação , Medula Espinal/patologia , Medula Espinal/cirurgia
6.
Med Sci Monit ; 18(11): BR450-60, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-23111736

RESUMO

BACKGROUND: To identify meningioma-specific proteins, cerebrospinal fluid (CSF) from 4 patients with a meningioma and 4 patients with a non-brain tumorous lesion were analyzed. MATERIAL/METHODS: Two-dimensional electrophoresis and electrospray quadrupole time-of-flight tandem mass spectrometry analyses revealed 10 unique spots, containing 11 independent proteins (spot #2 and #4 each contained 2 proteins and spot #3 was not identified) were evident in CSF associated with human meningioma: serum albumin precursor (3 different isoforms), Apolipoprotein E (Apo E), Apolipoprotein J precursor (Apo J), Transthyretin precursor (TTR), Prostaglandin D2 synthase 21 kDa (PTGDS), proapolipoprotein, Chain D hemoglobin Ypsilanti, alpha-1-antitrypsin (AAT), and beta-2-microglobulin precursor (ß2M). RESULTS: The contents of Apo E, Apo J and AAT were increased, while PTGDS, TTR and ß2M were decreased. CONCLUSIONS: The results observed by 2-dimensional electrophoresis were verified by Western blot analysis. The unique proteins may represent possible candidate biomarkers of meningioma.


Assuntos
Biomarcadores Tumorais/líquido cefalorraquidiano , Neoplasias Meníngeas/líquido cefalorraquidiano , Neoplasias Meníngeas/diagnóstico , Meningioma/líquido cefalorraquidiano , Meningioma/diagnóstico , Proteoma/metabolismo , Proteômica/métodos , Adulto , Idoso , Sequência de Aminoácidos , Western Blotting , Eletroforese em Gel Bidimensional , Feminino , Humanos , Imuno-Histoquímica , Masculino , Pessoa de Meia-Idade , Anotação de Sequência Molecular , Dados de Sequência Molecular , Proteínas de Neoplasias/líquido cefalorraquidiano , Proteínas de Neoplasias/química , Proteoma/química , Reprodutibilidade dos Testes , Espectrometria de Massas por Ionização por Electrospray
7.
J Neurooncol ; 107(1): 121-31, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21971737

RESUMO

The role of cerebrospinal fluid (CSF) in the pathogenesis of meningiomas is unknown. Cell cultures from three human leptomeninges, five WHO grade I and seven grade II meningiomas were treated with remnant CSF from 22 patients with no central nervous system disease and normal cell indices. Cells were evaluated by CyQUANT for DNA synthesis/cell proliferation and by western blots for phosphorylation/activation of growth regulatory pathways activated in meningiomas including JAK1-STAT3, MEK1-p44/42MAPK, Akt-mTOR and Rb. Analysis of Caspase 3 activation and survivin was also performed. Finally, the effects of PDGF neutralizing antibody and cucurbitacin, a STAT3 inhibitor on CSF stimulation were tested. Compared to controls and the mitogen PDGF-BB, various CSF samples significantly stimulated DNA synthesis/cell proliferation in 20 and 22 week leptomeningeal cultures and all of the grade I and II meningioma cells tested. Collectively CSF samples, from multiple different patients, stimulated DNA synthesis in tests of 23 of 32 grade I and 18 of 28 grade II meningioma cells. CSF stimulated phosphorylation/activation of STAT3 and reduced p44/42 MAPK in the leptomeningeal, all three grade I and 1 of three grade II meningioma cells. CSF did not affect Caspase 3 activity or survivin levels. PDGF neutralizing antibody had no effect on CSF stimulation but cucurbitacin blocked PDGF and CSF stimulation. While there are limitations to the CSF available since they were not from "normal" volunteers, the studies suggest that, in some settings, CSF is potentially mitogenic to leptomeningeal and meningioma cells and may act, in part, via activation of STAT3.


Assuntos
Proliferação de Células , Neoplasias Meníngeas/líquido cefalorraquidiano , Neoplasias Meníngeas/patologia , Meningioma/líquido cefalorraquidiano , Meningioma/patologia , Doenças do Sistema Nervoso/líquido cefalorraquidiano , Fator de Transcrição STAT3/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Anticorpos Monoclonais/farmacologia , Becaplermina , Caspase 3/metabolismo , Replicação do DNA , Feminino , Humanos , Immunoblotting , Proteínas Inibidoras de Apoptose/metabolismo , MAP Quinase Quinase 1/metabolismo , MAP Quinase Quinase 2/metabolismo , Masculino , Neoplasias Meníngeas/metabolismo , Meningioma/metabolismo , Pessoa de Meia-Idade , Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Fosforilação , Fator de Crescimento Derivado de Plaquetas/antagonistas & inibidores , Fator de Crescimento Derivado de Plaquetas/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Proteínas Proto-Oncogênicas c-sis/metabolismo , Proteína do Retinoblastoma/metabolismo , Fator de Transcrição STAT3/antagonistas & inibidores , Transdução de Sinais , Survivina , Serina-Treonina Quinases TOR/metabolismo , Adulto Jovem
8.
Chin Med J (Engl) ; 124(10): 1597-9, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21740827

RESUMO

Malignant meningiomas are uncommon intracranial tumors. The metastasis of malignant meningiomas to distant extracranial sites are well known. However, dissemination of the tumours in the cerebrospinal fluid (CSF) is rare and few cases have been reported. We present a case of histologically proven malignant meningioma with CSF dissemination at the remote intracranial area and into the spinal canal detected with magnetic resonance imaging.


Assuntos
Neoplasias Encefálicas/líquido cefalorraquidiano , Neoplasias Encefálicas/complicações , Meningioma/líquido cefalorraquidiano , Meningioma/complicações , Adulto , Feminino , Humanos , Adulto Jovem
9.
J Neurosurg ; 114(3): 714-8, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20707618

RESUMO

OBJECT: There are various schools of thought when it comes to dural reconstruction following meningioma surgery, which are largely based on the personal experience of the individual surgeons. The authors' aim in this study was to review different dural reconstruction techniques, with an emphasis on their experience with the synthetic onlay dural graft technique. METHODS: The medical records of 439 consecutive patients who were surgically treated for an intracranial meningioma over a period of 7 years, and for whom dural reconstruction was performed using the onlay dural graft DuraGen (Integra Neurosciences) were reviewed retrospectively. The most common tumor location was the convexity (27.6%), and 12% of the patients had undergone previous surgery. Complications related to the closure technique and/or closure material, such as CSF leakage from the incision, rhinorrhea, or infectious or chemical meningitis were reviewed. RESULTS: A CSF leak was encountered in 2 patients (0.4%), and 10 patients (2.3%) experienced graft-related complications in the form of chemical meningitis, cerebritis, and accumulation of extraaxial fluid. Infectious complications were seen in 4 patients (0.9%; bacterial meningitis, osteomyelitis, epidural abscess). None of the patients had pseudomeningocele that required a second intervention. CONCLUSIONS: In the authors' experience, the incidence of CSF leakage following non-watertight reconstruction of the dura mater in meningioma surgery performed using dural onlay graft was 0.4%. Graft-related complications occurred in 2.3%. These figures compare favorably to the majority of the series in which watertight dural closure is described and emphasized.


Assuntos
Dura-Máter/cirurgia , Meningioma/cirurgia , Procedimentos Neurocirúrgicos/métodos , Procedimentos de Cirurgia Plástica/métodos , Telas Cirúrgicas , Rinorreia de Líquido Cefalorraquidiano/etiologia , Colágeno , Humanos , Inflamação/etiologia , Meningioma/líquido cefalorraquidiano , Meningites Bacterianas/etiologia , Complicações Pós-Operatórias/líquido cefalorraquidiano , Complicações Pós-Operatórias/epidemiologia , Estudos Retrospectivos , Telas Cirúrgicas/efeitos adversos
10.
J Clin Neurosci ; 17(10): 1301-3, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20673720

RESUMO

The chordoid variant of meningioma is a histological subtype which carries with it a more aggressive clinical course and a propensity for recurrence. Similar to other meningioma subtypes, this lesion is encountered typically in the supratentorial compartment, often along the cerebral convexities. The chordoid meningioma subtype is found primarily in the adult population, and may occasionally be associated with the systemic manifestations of Castleman's disease. We present an adult patient with a rare chordoid meningioma located within the fourth ventricle. This lesion was treated with gross total resection. Chordoid meningioma must be considered within the differential diagnosis of intraventricular tumors. This histological subtype of meningioma warrants close follow-up. The patient must also be evaluated for systemic manifestations of Castleman's disease.


Assuntos
Neoplasias do Ventrículo Cerebral/patologia , Quarto Ventrículo/patologia , Neoplasias Meníngeas/patologia , Meningioma/patologia , Neoplasias do Ventrículo Cerebral/cirurgia , Quarto Ventrículo/cirurgia , Proteína Glial Fibrilar Ácida/metabolismo , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Neoplasias Meníngeas/sangue , Neoplasias Meníngeas/líquido cefalorraquidiano , Neoplasias Meníngeas/cirurgia , Meningioma/sangue , Meningioma/líquido cefalorraquidiano , Meningioma/cirurgia , Ventriculostomia/métodos , Adulto Jovem
11.
Acta Radiol ; 50(6): 682-9, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19449234

RESUMO

BACKGROUND: Conventional magnetic resonance (MR) imaging has a number of limitations in the diagnosis of the most common intracranial brain tumors, including tumor specification and the detection of tumoral infiltration in regions of peritumoral edema. PURPOSE: To prospectively assess if diffusion-weighted MR imaging (DWI) could be used to differentiate between different types of brain tumors and to distinguish between peritumoral infiltration in high-grade gliomas, lymphomas, and pure vasogenic edema in metastases and meningiomas. MATERIAL AND METHODS: MR imaging and DWI was performed on 93 patients with newly diagnosed brain tumors: 59 patients had histologically verified high-grade gliomas (37 glioblastomas multiforme, 22 anaplastic astrocytomas), 23 patients had metastatic brain tumors, five patients had primary cerebral lymphomas, and six patients had meningiomas. Apparent diffusion coefficient (ADC) values of tumor (enhancing regions or the solid portion of tumor) and peritumoral edema, and ADC ratios (ADC of tumor or peritumoral edema to ADC of contralateral white matter, ADC of tumor to ADC of peritumoral edema) were compared with the histologic diagnosis. ADC values and ratios of high-grade gliomas, primary cerebral lymphomas, metastases, and meningiomas were compared by using ANOVA and multiple comparisons. Optimal thresholds of ADC values and ADC ratios for distinguishing high-grade gliomas from metastases were determined by receiver operating characteristic (ROC) curve analysis. RESULTS: Statistically significant differences were found for minimum and mean of ADC tumor and ADC tumor ratio values between metastases and high-grade gliomas when including only one factor at a time. Including a combination of in total four parameters (mean ADC tumor, and minimum, maximum and mean ADC tumor ratio) resulted in sensitivity, specificity, positive (PPV), and negative predictive values (NPV) of 72.9, 82.6, 91.5, and 54.3% respectively. In the ROC curve analysis, the area under the curve of the combined four parameters was the largest (0.84), indicating a good test. CONCLUSION: Our results suggest that ADC values and ADC ratios (minimum and mean of ADC tumor and ADC tumor ratio) may be helpful in the differentiation of metastases from high-grade gliomas. It cannot distinguish high-grade gliomas from lymphomas, and lymphomas from metastases. ADC values and ADC ratios in peritumoral edema cannot be used to differentiate edema with infiltration of tumor cells from vasogenic edema when measurements for high-grade gliomas, lymphomas, metastases, and meningiomas were compared.


Assuntos
Edema Encefálico/patologia , Neoplasias Encefálicas/patologia , Glioma/patologia , Linfoma/patologia , Meningioma/patologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Edema Encefálico/líquido cefalorraquidiano , Edema Encefálico/diagnóstico , Neoplasias Encefálicas/secundário , Diagnóstico Diferencial , Imagem de Difusão por Ressonância Magnética/métodos , Glioma/líquido cefalorraquidiano , Glioma/diagnóstico , Humanos , Linfoma/líquido cefalorraquidiano , Linfoma/diagnóstico , Imageamento por Ressonância Magnética/métodos , Meningioma/líquido cefalorraquidiano , Meningioma/diagnóstico , Pessoa de Meia-Idade , Razão de Chances , Estudos Prospectivos , Curva ROC , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
12.
Med Oncol ; 26(2): 242-6, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-18937081

RESUMO

In this paper, we report a rare case of a 29-year-old boy who presented with papillary meningioma originating from the posterior fossa meninges. After a long, disease-free period, however, spinal drop metastases occurred 32 months after resection of the primary tumor. The primary and metastatic lesions had a similar histological appearance, meaning that multiple spinal metastatic lesions occurred through CSF route even after a gross total resection of the tumor. Tumor seeding during surgery is the evident reason for spinal metastasis, although we strictly adhered to the standard precautions for operations for malignant tumors such as obstruction of the cisterna magna with cotton paddies, and changing surgical gloves and instruments during the operation. In this report, we briefly discuss an exceedingly rare variant of meningioma, the papillary variant, and suggest a new approach, a CSF sampling, in the management of both malignant and benign meningiomas. CSF sampling allows for the early detection of metastasis and of tumor cells before metastasis has occurred, thus allowing treatment to begin as soon as possible. This early detection and management is possibly associated with longer survival. Furthermore, we discussed that meningiomas are tumors that are not as benign as initially thought.


Assuntos
Neoplasias Meníngeas/patologia , Meningioma/secundário , Neoplasias da Medula Espinal/secundário , Adulto , Líquido Cefalorraquidiano/citologia , Humanos , Imageamento por Ressonância Magnética , Masculino , Neoplasias Meníngeas/líquido cefalorraquidiano , Meningioma/líquido cefalorraquidiano , Meningioma/patologia , Neoplasias da Medula Espinal/líquido cefalorraquidiano , Neoplasias da Medula Espinal/patologia
14.
Eur J Ophthalmol ; 17(3): 454-8, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17534836

RESUMO

PURPOSE: To report a patient with optic nerve (ON) sheath meningioma, unilateral optic disc swelling, and inhomogeneous cerebrospinal fluid (CSF) composition between lumbar CSF and CSF from the subarachnoid space (SAS) of the affected ON. METHODS: A 39-year-old woman presented with unilateral optic disc swelling and slight deterioration of visual function in the left eye. Extensive laboratory workup and magnetic resonance imaging (MRI) of the brain and orbits were performed. As radiotherapy was refused by the patient, ON sheath fenestration (ONSF) was offered and performed in order to stop deterioration. CSF from the SAS of the ON was sampled. RESULTS: Laboratory workup was within normal limits. MRI of the left orbit demonstrated enhancement of the dura in the precanalicular portion of the ON and distension of the SAS, most prominent in the bulbar portion of the ON. On lumbar puncture the opening pressure measured 19 (cm H2O). Compared to the lumbar CSF the CSF of the affected ON SAS showed markedly elevated measurements for albumin, IgG, and beta-trace protein. Visual function remained stable over a follow-up time of 18 months. CONCLUSIONS: Composition of CSF is considered to be homogenous throughout all CSF spaces. In this patient the authors found a marked concentration-gradient of albumin, IgG, and beta-trace protein between the CSF in the spinal canal and the CSF in the SAS of the affected ON. Based on the radiologic features of the left ON and the dissociated beta-trace protein concentrations in the CSF of the SAS of the ON and the lumbar CSF, the diagnosis of an ON sheath compartment syndrome due to an ON sheath meningioma was made.


Assuntos
Síndromes Compartimentais/etiologia , Meningioma/complicações , Neoplasias do Nervo Óptico/complicações , Papiledema/etiologia , Adulto , Albuminas/líquido cefalorraquidiano , Pressão do Líquido Cefalorraquidiano , Síndromes Compartimentais/líquido cefalorraquidiano , Síndromes Compartimentais/diagnóstico , Síndromes Compartimentais/cirurgia , Descompressão Cirúrgica , Feminino , Humanos , Imunoglobulina G/líquido cefalorraquidiano , Oxirredutases Intramoleculares/líquido cefalorraquidiano , Lipocalinas , Região Lombossacral , Imageamento por Ressonância Magnética , Meningioma/líquido cefalorraquidiano , Meningioma/patologia , Neoplasias do Nervo Óptico/líquido cefalorraquidiano , Neoplasias do Nervo Óptico/patologia , Papiledema/líquido cefalorraquidiano , Papiledema/diagnóstico , Papiledema/cirurgia , Punção Espinal , Espaço Subaracnóideo , Campos Visuais
16.
J Am Vet Med Assoc ; 228(4): 564-7, 2006 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-16478433

RESUMO

OBJECTIVE: To determine CSF characteristics associated with intracranial meningiomas in dogs. DESIGN: Retrospective case series. ANIMALS: 56 dogs with intracranial meningiomas. PROCEDURES: Medical records of dogs with a histopathologic diagnosis of intracranial meningioma, in which CSF analysis had been performed, were reviewed. Information concerning total nucleated cell counts (TNCCs) and differential nucleated cell counts, RBC counts, and total protein concentration in CSF; seizure history and glucocorticoid administration; and location of meningiomas was recorded. RESULTS: TNCCs < 5 cells/microL were detected in 41 of 56 (73%) dogs; 5 of 56 (9%) dogs had TNCCs > 50 cells/microL. Analysis of CSF revealed predominantly neutrophilic pleocytosis in < 20% of dogs. There was a significant association between meningioma location (caudal portion of the cranial fossa or middle and rostral portion of the cranial fossae) and increased TNCCs (> or = 5 cells/microL). CONCLUSIONS AND CLINICAL RELEVANCE: Results were significantly different from those routinely reported in the veterinary literature. Neutrophilic pleocytosis, especially with TNCCs > 50 cells/microL, was not typical in CSF samples from dogs with intracranial meningiomas. Neutrophilic pleocytosis may not be detected in CSF samples from dogs with meningiomas located within the middle or rostral portion of the cranial fossae.


Assuntos
Líquido Cefalorraquidiano/citologia , Doenças do Cão/líquido cefalorraquidiano , Meningioma/veterinária , Animais , Proteínas do Líquido Cefalorraquidiano/análise , Cisterna Magna/citologia , Cães , Eritroblastos , Contagem de Eritrócitos/veterinária , Meningioma/líquido cefalorraquidiano , Estudos Retrospectivos
17.
J Neurosurg Spine ; 3(2): 153-8, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16370305

RESUMO

The authors report the case of a 23-year-old man who presented with a C1-3 spinal mass. Following intraspinal decompression the tumor was histologically classified as an atypical meningioma (World Health Organization grade II). Two further surgical interventions resulted in almost total removal of the meningioma. In addition, radiotherapy was performed. During the 1.5-year follow-up period the diagnostic examinations identified a local tumor recurrence, an intraspinal C-6 metastasis, and a segmental instability with anterior C2-3 slippage and C3-4 kyphosis. The tumor was resected and occipitocervical stabilization was performed. Histological examination showed no change in malignancy. Despite additional hydroxyurea-based chemotherapy, the patient presented 4 months later with a hemiparesis and a massive recurrence of the tumor mass involving the posterior fossa and the upper thoracic spine. Because there were no further therapeutical options, the patient died. The authors discuss more aggressive therapeutic options in addition to surgery in patients with metastatic atypical meningiomas. The results in the reported case indicate that meningiomas associated with cerebrospinal fluid metastasis may represent a higher grade of malignancy.


Assuntos
Neoplasias Meníngeas/cirurgia , Meningioma/cirurgia , Neoplasias da Medula Espinal/cirurgia , Adulto , Antineoplásicos/uso terapêutico , Vértebras Cervicais , Descompressão Cirúrgica , Progressão da Doença , Evolução Fatal , Humanos , Hidroxiureia/uso terapêutico , Instabilidade Articular/etiologia , Imageamento por Ressonância Magnética , Masculino , Neoplasias Meníngeas/líquido cefalorraquidiano , Neoplasias Meníngeas/diagnóstico , Neoplasias Meníngeas/secundário , Meningioma/líquido cefalorraquidiano , Meningioma/diagnóstico , Meningioma/secundário , Mielografia , Metástase Neoplásica , Recidiva Local de Neoplasia , Procedimentos Neurocirúrgicos/efeitos adversos , Radioterapia Adjuvante , Reoperação , Neoplasias da Medula Espinal/líquido cefalorraquidiano , Neoplasias da Medula Espinal/diagnóstico , Neoplasias da Medula Espinal/secundário , Doenças da Coluna Vertebral/etiologia
18.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 34(2): 141-7, 2005 03.
Artigo em Chinês | MEDLINE | ID: mdl-15812888

RESUMO

OBJECTIVE: To establish the diagnostic model of cerebrospinal protein profile for gliomas by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) and bioinformatics. METHODS: Seventy-five samples of cerebrospinal fluid from patients with gliomas, benign brain tumors and mild brain traumas were collected. A total of 50 samples from gliomas and non-brain-tumors were divided into training sets (33 cases including 17 gliomas and 16 non-brain-tumors) and testing sets (17 cases including 5 gliomas and 12 non-brain-tumors). The cerebrospinal proteins bound to H4 chip were detected by SELDI-TOF MS, the profiles of cerebrospinal protein were gained and then analyzed with artificial neural network algorithm (ANN); and the diagnostic model of cerebrospinal protein profiles for differentiating gliomas from non-brain-tumors was established. Forty-seven of cerebrospinal samples of gliomas and benign brain tumors were divided into training sets (31 cases including 13 gliomas and 18 benign brain tumors) and testing sets (16 cases including 9 gliomas and 7 benign brain tumors), the diagnostic model of cerebrospinal protein profiles for differentiating gliomas from benign brain tumors was established based on the same method. The support vector machine (SVM) algorithm was also used for evaluation, both results were very similar, but the result derived from ANN was more stable than that from SVM. RESULT: The diagnostic model of cerebrospinal protein profiles for differentiating gliomas from non-brain-tumors was established and was challenged with the test set randomly, the sensitivity and specificity were 100% and 91.7%, respectively. The cerebrospinal protein profiling model for differentiating gliomas from benign brain tumors was also developed and was challenged with the test set randomly, the sensitivity and specificity were 88.9%, and 100%, respectively. CONCLUSION: The technology of SELDI-TOF MS which combined with analysis tools of bioinformatics is a novel effective method for screening and identifying tumor biomarkers of gliomas and it may provide a new approach for the clinical diagnosis of glioma.


Assuntos
Neoplasias Encefálicas/líquido cefalorraquidiano , Proteínas do Líquido Cefalorraquidiano/genética , Glioma/líquido cefalorraquidiano , Mapeamento de Peptídeos/normas , Adulto , Idoso , Algoritmos , Biomarcadores Tumorais , Neoplasias Encefálicas/diagnóstico , Diagnóstico Diferencial , Feminino , Glioma/diagnóstico , Humanos , Masculino , Meningioma/líquido cefalorraquidiano , Meningioma/diagnóstico , Pessoa de Meia-Idade , Redes Neurais de Computação , Sensibilidade e Especificidade , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
19.
J Neurosurg ; 101(6): 1045-8, 2004 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-15597767

RESUMO

Solitary fibrous tumor (SFT) is a benign and rare neoplasm. To date, only 37 patients with intracranial SFTs have been reported. Although a number of the tumors were recurrent and some later underwent malignant transformation, none of these lesions progressed to cerebrospinal fluid (CSF) dissemination. In this paper the authors report a case of SFT in which the lesion recurred several times and ultimately was disseminated by the CSF. The patient was a 63-year-old woman with multiple intracranial and spinal tumors. Fifteen years before this presentation, at the age of 48 she had been hospitalized for resection of a falcotentorial tumor. During the ensuing 15 years she underwent multiple surgeries and sessions of radiation therapy for recurrent lesions. The exclusive location of her tumors in the subarachnoid space at the end of this 15-year period indicate CSF dissemination of the tumor. The tumor that was resected when the patient was 48 years old and the latest resected lesion were analyzed by performing immunohistological CD34, epithelial membrane antigen, vimentin, S100 protein, and reticulin staining, and determining the MIB-1 labeling index (LI). Most of the results were identical, and both tumors were diagnosed as SFT according to a staining pattern that showed a strong and diffuse positive reaction for CD34. Nevertheless, the authors noted that the MIB-1 LI increased from less than 1% in the original tumor to 13% in the latest tumor. The increased proliferation of MIB-1 indicates that the malignant transformation could have occurred during tumor recurrence with CSF dissemination.


Assuntos
Fibroma/patologia , Neoplasias Meníngeas/patologia , Meningioma/patologia , Recidiva Local de Neoplasia/patologia , Antígenos CD34/metabolismo , Feminino , Fibroma/líquido cefalorraquidiano , Fibroma/cirurgia , Humanos , Antígeno Ki-67/metabolismo , Imageamento por Ressonância Magnética , Neoplasias Meníngeas/líquido cefalorraquidiano , Neoplasias Meníngeas/cirurgia , Meningioma/líquido cefalorraquidiano , Meningioma/cirurgia , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/líquido cefalorraquidiano , Recidiva Local de Neoplasia/cirurgia
20.
Oncogene ; 23(12): 2231-5, 2004 Mar 18.
Artigo em Inglês | MEDLINE | ID: mdl-14676832

RESUMO

Simian virus 40 (SV40) is a DNA tumor virus known to induce cancers in laboratory animals. There are numerous reports of the detection of SV40 DNA and/or proteins in human malignancies of the same types as those induced by SV40 in animals, including brain cancers. However, known exposure to the virus has not yet been linked directly to cancer development in a specific individual. Here we describe the detection of SV40 sequences in the meningioma of a laboratory researcher who had a probable direct exposure to SV40 and subsequently developed a tumor positive for viral DNA sequences indistinguishable from those of the laboratory source. This case suggests a link between viral exposure and tumor development.


Assuntos
Neoplasias Encefálicas/virologia , Laboratórios Hospitalares , Pessoal de Laboratório Médico , Meningioma/virologia , Infecções por Polyomavirus , Vírus 40 dos Símios/imunologia , Infecções Tumorais por Vírus , Adulto , Antígenos Transformantes de Poliomavirus/genética , Antígenos Transformantes de Poliomavirus/imunologia , Neoplasias Encefálicas/líquido cefalorraquidiano , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/etiologia , Neoplasias Encefálicas/patologia , Neoplasias Encefálicas/cirurgia , Linhagem Celular Tumoral , Feminino , Gadolínio , Humanos , Imageamento por Ressonância Magnética , Meningioma/líquido cefalorraquidiano , Meningioma/diagnóstico , Meningioma/etiologia , Meningioma/patologia , Meningioma/cirurgia , Reação em Cadeia da Polimerase , Polimorfismo Genético , Fatores de Risco , Análise de Sequência de DNA , Texas , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA